Soft Tissue Repair Market by Product (Mesh/Tissue patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments), Application (Hernia, Dural, Orthopedic, Skin, Dental, Vaginal, Breast augmentation) - Global Forecast to 2027
MarketsandMarkets expects the soft tissue repair market is projected to reach USD 17.2Billion by 2027 from USD 13.6Billion in 2022, at a CAGR of 4.7% during the forecast period. Growth in this market is mainly driven by Increasing aging population and obesity rate, growing incidence of sports injuries, strong focus on R&D leading to the launch of technologically advanced products, and increasing volume of surgeries and growing prevalence of severe trauma injuries. This, in turn, unfavorable reimbursement scenario and high price of soft tissue repair products and the rising cost of surgical procedures are the key factors restraining the growth of the market. In this report, the soft tissue repair market is segmented on the basis of product, application, end user, and region.
In this report, the soft tissue repair market is segmented on the basis of product, application, end user, and region.
“Tissue Patched/Mashes accounted for the largest share in the soft tissue repair market by product type”
Based on product, soft tissue repair market is segmented into tissue patch/mash and laproscopicintrument injectors. In 2021, Tissue Patch/Mesh accounted for the larger share of 91.9% of the soft tissue repair market. This product segment is projected to reach USD 15,892.3 million by 2027 from 12,547.2 million in 2022, at a CAGR of 4.8% during the forecast period. The large share of this segment is attributed to the increasing use of synthetic Mesh across different types of orthopedic surgeries as they reduce surgical time.
“Hernia Repair accounted for the largest share in the soft tissue repair market by Application”
Based on application type, the soft tissue repair market is segmented into Hernia Repair, Dural Repair, Vaginal Sling Procedures, Skin Repair, Orthopedic repair, Dental repair, Breast Reconstruction Repair, and other applications. In 2021, the hernia repair is estimated to account for the largest share of 26.5% of the soft tissue repair market, by application. The increasing incidence of hernia cases, sports injuries and the growing prevalence of lifestyle disorders, such as arthritis, osteoporosis, and obesity (leading to orthopedic problems), are some of the major factors responsible for the growth in the number of soft tissue repair surgeries performed globally.
“Hospital segment accounted for the largest share in the soft tissue repair market by End User”
Based on end users, the soft tissue repair market is segmented into hospitals, clinics, and other end users (ambulatory surgery centers, emergency care centers, burn care centers, and research institutes). The hospitals segment accounted for the largest share of 93.3% of the soft tissue repair market in 2021. This is primarily attributed to the increasing number of surgeries taking place across the globe due to the rising geriatric population and the incidence of various diseases. Moreover, the increasing need to control blood loss and achieve efficient hemostasis and wound closure in trauma cases, injuries, or surgical procedures is leading to the increasing adoption of soft tissue repair products by surgeons.
“North America segment accounted for the largest share in the soft tissue repair market by Region”
On the basis of region, the soft tissue repair market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the largest share of 43.5% of the soft tissue repair market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of the North American market is attributed to the presence of an advanced healthcare system in the region, high and growing number of surgical procedures, higher adoption of advanced products, and the presence of several leading market players in the US.
Key Market Players:
Prominent players in the soft tissue repair market include Smith & Nephew Plc. (UK), Arthrex, Inc. (US), Stryker Corporation (US), Johnson & Johnson (US), Medtronic Plc. (IE), LifeNet Health, Inc. (US), Becton, Dickinson and Company (US), Integra LifeSciences Corporation (US), CryoLife, Inc. (US), Organogenesis Inc. (US), Zimmer Biomet (US), Baxter International, Inc. (US), ACell Inc. (US), Tissue Regenix Group Plc (UK) and Aroa Biosurgery Ltd. (NZ). These players have adopted various growth strategies such as acquisition, product launches, and expansion to increase their presence and reach in the soft tissue repair market.
A breakdown of the primary participants (supply-side) for the soft tissue repair market referred to for this report is provided below:
The market study covers the soft tissue repair market across various segments. It aims at estimating the market sizeand the growth potential of this market across different segmentsby product, by application, by end user, and by region.The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the soft tissue repairmarket and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.
In this report, the soft tissue repair market is segmented on the basis of product, application, end user, and region.
“Tissue Patched/Mashes accounted for the largest share in the soft tissue repair market by product type”
Based on product, soft tissue repair market is segmented into tissue patch/mash and laproscopicintrument injectors. In 2021, Tissue Patch/Mesh accounted for the larger share of 91.9% of the soft tissue repair market. This product segment is projected to reach USD 15,892.3 million by 2027 from 12,547.2 million in 2022, at a CAGR of 4.8% during the forecast period. The large share of this segment is attributed to the increasing use of synthetic Mesh across different types of orthopedic surgeries as they reduce surgical time.
“Hernia Repair accounted for the largest share in the soft tissue repair market by Application”
Based on application type, the soft tissue repair market is segmented into Hernia Repair, Dural Repair, Vaginal Sling Procedures, Skin Repair, Orthopedic repair, Dental repair, Breast Reconstruction Repair, and other applications. In 2021, the hernia repair is estimated to account for the largest share of 26.5% of the soft tissue repair market, by application. The increasing incidence of hernia cases, sports injuries and the growing prevalence of lifestyle disorders, such as arthritis, osteoporosis, and obesity (leading to orthopedic problems), are some of the major factors responsible for the growth in the number of soft tissue repair surgeries performed globally.
“Hospital segment accounted for the largest share in the soft tissue repair market by End User”
Based on end users, the soft tissue repair market is segmented into hospitals, clinics, and other end users (ambulatory surgery centers, emergency care centers, burn care centers, and research institutes). The hospitals segment accounted for the largest share of 93.3% of the soft tissue repair market in 2021. This is primarily attributed to the increasing number of surgeries taking place across the globe due to the rising geriatric population and the incidence of various diseases. Moreover, the increasing need to control blood loss and achieve efficient hemostasis and wound closure in trauma cases, injuries, or surgical procedures is leading to the increasing adoption of soft tissue repair products by surgeons.
“North America segment accounted for the largest share in the soft tissue repair market by Region”
On the basis of region, the soft tissue repair market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the largest share of 43.5% of the soft tissue repair market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The large share of the North American market is attributed to the presence of an advanced healthcare system in the region, high and growing number of surgical procedures, higher adoption of advanced products, and the presence of several leading market players in the US.
Key Market Players:
Prominent players in the soft tissue repair market include Smith & Nephew Plc. (UK), Arthrex, Inc. (US), Stryker Corporation (US), Johnson & Johnson (US), Medtronic Plc. (IE), LifeNet Health, Inc. (US), Becton, Dickinson and Company (US), Integra LifeSciences Corporation (US), CryoLife, Inc. (US), Organogenesis Inc. (US), Zimmer Biomet (US), Baxter International, Inc. (US), ACell Inc. (US), Tissue Regenix Group Plc (UK) and Aroa Biosurgery Ltd. (NZ). These players have adopted various growth strategies such as acquisition, product launches, and expansion to increase their presence and reach in the soft tissue repair market.
A breakdown of the primary participants (supply-side) for the soft tissue repair market referred to for this report is provided below:
- By Company Type: Tier 1–5%, Tier 2–15%, and Tier 3–80%
- By Designation: C-level–45%, Director Level–25%, and Others–30%
- By Region: North America–36%, Europe–26%, Asia Pacific–21%, Latin America- 10%, and Middle East and Africa– 7%
The market study covers the soft tissue repair market across various segments. It aims at estimating the market sizeand the growth potential of this market across different segmentsby product, by application, by end user, and by region.The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the soft tissue repairmarket and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 MARKETS COVERED – BY REGION
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Breakdown of primaries
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2020)
FIGURE 5 SUPPLY-SIDE ANALYSIS: SOFT TISSUE REPAIR MARKET
FIGURE 6 TOP-DOWN APPROACH
FIGURE 7 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE SOFT TISSUE REPAIR MARKET (2022–2027)
2.3 GROWTH FORECAST
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF THE SOFT TISSUE
REPAIR MARKET (2021)
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.5 KEY INDUSTRY INSIGHTS
2.6 LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
2.8 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
FIGURE 10 SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 11 SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 12 SOFT TISSUE REPAIR MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE SOFT TISSUE REPAIR MARKET
4 PREMIUM INSIGHTS
4.1 SOFT TISSUE REPAIR SYSTEM MARKET OVERVIEW
FIGURE 14 INCREASING HERNIA CASES AND TRAUMA INJURIES AND
GROWING R&D DRIVE THE MARKET
4.2 REGIONAL MIX: SOFT TISSUE REPAIR MARKET
FIGURE 15 APAC TO REGISTER THE HIGHEST CAGR OF DURING THE FORECAST PERIOD
4.3 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY PRODUCT AND COUNTRY (2021)
FIGURE 16 TISSUE PATCHES/MESHES ACCOUNTED FOR THE LARGEST SHARE
OF THE ASIA PACIFIC MARKET IN 2021
4.4 SOFT TISSUE REPAIR MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 CHINA TO REGISTER THE HIGHEST REVENUE GROWTH DURING
THE FORECAST PERIOD
4.5 SOFT TISSUE REPAIR MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 18 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE
DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Increasing aging population and obesity rate
5.2.1.2 Growing incidence of sports injuries
5.2.1.3 Strong focus on R&D
5.2.1.4 Increasing volume of surgeries and growing prevalence of
severe trauma injuries
TABLE 2 UK: INCREASE IN THE NUMBER OF CARDIAC SURGICAL
PROCEDURES PERFORMED
5.2.2 RESTRAINTS
5.2.2.1 Unfavorable reimbursement scenario
5.2.2.2 High product and procedure costs
5.2.3 OPPORTUNITIES
5.2.3.1 Growing adoption of advanced soft tissue repair products in emerging markets
TABLE 3 COST OF SURGICAL PROCEDURES: US VS. INDIA (USD)
5.2.3.2 Growing use of combination materials for enhancing product efficacy
5.2.4 CHALLENGES
5.2.4.1 Stringent regulatory framework
5.2.4.2 Need for skilled personnel
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON ECONOMIC SCENARIO IN
SOFT TISSUE REPAIR MARKET
5.4 ECOSYSTEM ANALYSIS
FIGURE 19 SOFT TISSUE REPAIR MARKET: ECOSYSTEM ANALYSIS
5.5 PRICING ANALYSIS
TABLE 4 AVERAGE SELLING PRICE FOR SOFT TISSUE REPAIR PRODUCTS
5.6 SUPPLY CHAIN ANALYSIS
FIGURE 20 SUPPLY CHAIN ANALYSIS: SOFT TISSUE REPAIR MARKET (2021)
5.7 PATENT ANALYSIS
5.7.1 PATENT PUBLICATION TRENDS FOR SOFT TISSUE REPAIR MARKET
FIGURE 21 GLOBAL PATENT PUBLICATION TRENDS IN SOFT TISSUE REPAIR, 2016–2021
5.7.2 TOP APPLICANTS (COMPANIES) OF SOFT TISSUE REPAIR PATENTS
FIGURE 22 TOP COMPANIES THAT APPLIED FOR SOFT TISSUE REPAIR PRODUCT PATENTS, 2016–2021
5.7.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE SOFT TISSUE REPAIR MARKET
FIGURE 23 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR SOFT TISSUE REPAIR PATENTS, 2016–2021
5.8 VALUE CHAIN ANALYSIS
FIGURE 24 SOFT TISSUE REPAIR MARKET: VALUE CHAIN ANALYSIS (2021)
5.9 TECHNOLOGY ANALYSIS
5.10 KEY CONFERENCES & EVENTS IN 2022–2023
5.11 REGULATORY LANDSCAPE
TABLE 5 REGULATORY STANDARDS/APPROVALS REQUIRED FOR SOFT TISSUE
REPAIR PRODUCTS, BY COUNTRY/REGION
5.12 PORTER’S FIVE FORCES ANALYSIS
TABLE 6 SOFT TISSUE REPAIR MARKET: PORTER’S FIVE FORCES ANALYSIS
5.12.1 THREAT FROM NEW ENTRANTS
5.12.2 COMPETITIVE RIVALRY
5.12.3 BARGAINING POWER OF BUYERS
5.12.4 BARGAINING POWER OF SUPPLIERS
5.12.5 THREAT FROM SUBSTITUTES
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 25 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS
FOR TOP 3 APPLICATIONS
TABLE 7 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS
FOR TOP 3 APPLICATIONS (%)
5.13.2 BUYING CRITERIA
FIGURE 26 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
TABLE 8 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
6 SOFT TISSUE REPAIR MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 9 SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
6.2 TISSUE PATCHES/MESHES
TABLE 10 SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 11 SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
6.2.1 SYNTHETIC MESHES
6.2.1.1 Growing popularity is attributed to the availability of raw materials, lack of infectious disease transmission, cost-effectiveness
TABLE 12 SOFT TISSUE REPAIR MARKET FOR SYNTHETIC MESHES, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2 BIOLOGICAL MESHES
TABLE 13 SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 14 SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
6.2.2.1 Allografts
6.2.2.1.1 Biocompatibility and superior aesthetic results drive the use of allografts
TABLE 15 SOFT TISSUE REPAIR MARKET FOR ALLOGRAFTS, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2.2 Xenografts
6.2.2.2.1 Xenografts are more viable than allografts due to availability and size ranges
TABLE 16 SOFT TISSUE REPAIR MARKET FOR XENOGRAFTS, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.3 FIXATION PRODUCTS
TABLE 17 SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 18 SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
6.2.3.1 Suture anchors
6.2.3.1.1 Growing injury incidence and need for surgery drive demand for suture anchors
TABLE 19 SOFT TISSUE REPAIR MARKET FOR SUTURE ANCHORS, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.3.2 Interference screws
6.2.3.2.1 Availability of advanced biodegradable screws and development of biocomposites drives the market growth
TABLE 20 SOFT TISSUE REPAIR MARKET FOR INTERFERENCE SCREWS, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.3.3 Other fixation products
TABLE 21 SOFT TISSUE REPAIR MARKET FOR OTHER FIXATION PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 LAPAROSCOPIC INSTRUMENTS
6.3.1 QUICK RECOVERY, LOW PAIN & INFECTION RATES DRIVE DEMAND FOR LAPAROSCOPIC SURGERY AND ASSOCIATED INSTRUMENTS
TABLE 22 SOFT TISSUE REPAIR MARKET FOR LAPAROSCOPIC INSTRUMENTS, BY COUNTRY, 2020–2027 (USD MILLION)
7 SOFT TISSUE REPAIR MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 23 SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
7.2 HERNIA REPAIR
7.2.1 HERNIA REPAIR ACCOUNTS FOR THE LARGEST SHARE OF
THE SOFT TISSUE REPAIR MARKET
TABLE 24 SOFT TISSUE REPAIR MARKET FOR HERNIA REPAIR, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 SKIN REPAIR
7.3.1 INCREASING CASES OF CHRONIC WOUNDS, DIABETIC ULCERS, AND BURNS CONTRIBUTE TO GROWTH OF SKIN REPAIR MARKET
TABLE 25 SOFT TISSUE REPAIR MARKET FOR SKIN REPAIR, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 ORTHOPEDIC REPAIR
7.4.1 INCREASING NUMBER OF SPORTS INJURIES DRIVES
ORTHOPEDIC REPAIR MARKET
TABLE 26 SOFT TISSUE REPAIR MARKET FOR ORTHOPEDIC REPAIR, BY COUNTRY, 2020–2027 (USD MILLION)
7.5 DENTAL REPAIR
7.5.1 RISING DEMAND FOR PREVENTIVE AND COSMETIC DENTAL PROCEDURES DRIVES THE DENTAL REPAIR MARKET
TABLE 27 SOFT TISSUE REPAIR MARKET FOR DENTAL REPAIR, BY COUNTRY, 2020–2027 (USD MILLION)
7.6 BREAST RECONSTRUCTION
7.6.1 RISING BREAST CANCER PREVALENCE SUPPORTS MARKET GROWTH
TABLE 28 SOFT TISSUE REPAIR MARKET FOR BREAST RECONSTRUCTION, BY COUNTRY, 2020–2027 (USD MILLION)
7.7 DURAL REPAIR
7.7.1 RISING PREVALENCE OF NEUROVASCULAR DISORDERS AND AWARENESS DRIVES THE DURAL SOFT TISSUE REPAIR MARKET
TABLE 29 SOFT TISSUE REPAIR MARKET FOR DURAL REPAIR, BY COUNTRY, 2020–2027 (USD MILLION)
7.8 VAGINAL SLING PROCEDURES
7.8.1 DEMAND FOR VAGINAL SLING PROCEDURES BOLSTERED BY GROWING CASES OF STRESS-INDUCED URINARY INCONTINENCE (SUI) IN WOMEN
TABLE 30 SOFT TISSUE REPAIR MARKET FOR VAGINAL SLING PROCEDURES, BY COUNTRY, 2020–2027 (USD MILLION)
7.9 OTHER APPLICATIONS
TABLE 31 SOFT TISSUE REPAIR MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
8 SOFT TISSUE REPAIR MARKET, BY END USER
8.1 INTRODUCTION
TABLE 32 SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2 HOSPITALS
8.2.1 HOSPITALS ARE THE LARGEST END USERS OF
SOFT TISSUE REPAIR PRODUCTS
TABLE 33 SOFT TISSUE REPAIR MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 CLINICS
8.3.1 QUICKER CONSULTATION SERVICES AND MINIMAL PATIENT STAYS ARE ADVANTAGES OFFERED BY CLINICS OVER HOSPITALS
TABLE 34 SOFT TISSUE REPAIR MARKET FOR CLINICS, BY COUNTRY, 2020–2027(USD MILLION)
8.4 OTHER END USERS
TABLE 35 SOFT TISSUE REPAIR MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
9 SOFT TISSUE REPAIR MARKET, BY REGION
9.1 INTRODUCTION
FIGURE 27 INDIA AND CHINA TO REGISTER HIGHEST GROWTH RATES IN THE
SOFT TISSUE REPAIR MARKET
TABLE 36 SOFT TISSUE REPAIR MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 28 NORTH AMERICA: SOFT TISSUE REPAIR MARKET SNAPSHOT
TABLE 37 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 38 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 39 NORTH AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 40 NORTH AMERICA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 41 NORTH AMERICA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 42 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 43 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.1 US
9.2.1.1 Presence of prominent market players and high per capita income supports market growth in the US
TABLE 44 US: MACROECONOMIC INDICATORS
TABLE 45 US: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 46 US: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 47 US: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 48 US: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 49 US: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 50 US: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Rising healthcare expenditure and favorable public and private funding supports soft tissue repair market growth
TABLE 51 CANADA: MACROECONOMIC INDICATORS
TABLE 52 CANADA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 53 CANADA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 54 CANADA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 55 CANADA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 56 CANADA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 57 CANADA: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3 EUROPE
FIGURE 29 EUROPE: SOFT TISSUE REPAIR MARKET SNAPSHOT
TABLE 58 EUROPE: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 59 EUROPE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 60 EUROPE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 61 EUROPE: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 62 EUROPE: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 63 EUROPE: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 64 EUROPE: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Germany holds the largest share of the European market
TABLE 65 GERMANY: MACROECONOMIC INDICATORS
TABLE 66 GERMANY: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 67 GERMANY: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 68 GERMANY: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 69 GERMANY: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 70 GERMANY: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 71 GERMANY: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.2 FRANCE
9.3.2.1 Presence of a well-established healthcare system and growing geriatric population to boost the market growth
TABLE 72 FRANCE: MACROECONOMIC INDICATORS
TABLE 73 FRANCE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 74 FRANCE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 75 FRANCE: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 76 FRANCE: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 77 FRANCE: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 78 FRANCE: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.3 UK
9.3.3.1 Growing volume of hernia repair surgeries and cardiovascular surgeries in the UK stimulating market growth
TABLE 79 UK: MACROECONOMIC INDICATORS
TABLE 80 UK: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 81 UK: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 82 UK: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 83 UK: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 84 UK: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 85 UK: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Increasing volume of surgeries to drive the demand for soft tissue repair products in the country
TABLE 86 ITALY: MACROECONOMIC INDICATORS
TABLE 87 ITALY: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 88 ITALY: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 89 ITALY: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 90 ITALY: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 91 ITALY: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 92 ITALY: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Growing healthcare budget and rising efforts for boosting the local manufacturing of medical products to drive market growth
TABLE 93 SPAIN: MACROECONOMIC INDICATORS
TABLE 94 SPAIN: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 95 SPAIN: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 96 SPAIN: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 97 SPAIN: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 98 SPAIN: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 99 SPAIN: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 100 ROE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 101 ROE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 102 ROE: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 ROE: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 104 ROE: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 105 ROE: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 30 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET SNAPSHOT
TABLE 106 APAC: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 107 APAC: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 108 APAC: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 109 APAC: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 110 APAC: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 111 APAC: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 112 APAC: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Strong healthcare system and rising geriatric population to support market growth in Japan
TABLE 113 JAPAN: MACROECONOMIC INDICATORS
TABLE 114 JAPAN: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 115 JAPAN: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 116 JAPAN: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 117 JAPAN: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 118 JAPAN: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 119 JAPAN: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Growing number of hospitals and healthcare policy reforms stimulating market growth
TABLE 120 CHINA: MACROECONOMIC INDICATORS
TABLE 121 CHINA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 122 CHINA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 123 CHINA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 124 CHINA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 125 CHINA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 126 CHINA: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Rising healthcare awareness and favorable government support to stimulate market growth in India
TABLE 127 INDIA: MACROECONOMIC INDICATORS
TABLE 128 INDIA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 129 INDIA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 130 INDIA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 131 INDIA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 132 INDIA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 133 INDIA: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 134 ROAPAC: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 135 ROAPAC: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 136 ROAPAC: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 137 ROAPAC: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 138 ROAPAC: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 139 ROAPAC: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 LOW-COST SURGERIES ATTRACT MEDICAL TOURISTS TO LATIN AMERICA
TABLE 140 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 141 LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 142 LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 143 LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 144 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 145 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 MEA IS THE SMALLEST REGIONAL MARKET FOR BIOSURGERY PRODUCTS
TABLE 146 MEA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 147 MEA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 148 MEA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 149 MEA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 150 MEA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 151 MEA: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 31 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE
SOFT TISSUE REPAIR MARKET
10.4 MARKET SHARE ANALYSIS
FIGURE 32 SOFT TISSUE REPAIR MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
10.5 COMPANY EVALUATION QUADRANT
10.5.1 STARS
10.5.2 PERVASIVE PLAYERS
10.5.3 EMERGING LEADERS
10.5.4 PARTICIPANTS
FIGURE 33 SOFT TISSUE REPAIR MARKET: COMPANY EVALUATION MATRIX, 2021
10.6 COMPETITIVE LEADERSHIP MAPPING FOR SMES & START-UPS
10.6.1 PROGRESSIVE COMPANIES
10.6.2 DYNAMIC COMPANIES
10.6.3 STARTING BLOCKS
10.6.4 RESPONSIVE COMPANIES
FIGURE 34 SOFT TISSUE REPAIR MARKET: COMPANY EVALUATION MATRIX
FOR SMES & START-UP
10.7 COMPETITIVE BENCHMARKING
10.7.1 OVERALL COMPANY FOOTPRINT
TABLE 152 OVERALL COMPANY FOOTPRINT (25 COMPANIES)
TABLE 153 COMPANY FOOTPRINT: BY PRODUCT (25 COMPANIES)
TABLE 154 COMPANY FOOTPRINT: BY APPLICATION (25 COMPANIES)
TABLE 155 COMPANY FOOTPRINT: BY REGION (25 COMPANIES)
10.8 COMPETITIVE SCENARIO
10.8.1 DEALS
TABLE 156 DEALS
10.8.2 OTHER DEVELOPMENTS
TABLE 157 OTHER DEVELOPMENTS
11 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, and MnM View)*
11.1 KEY PLAYERS
11.1.1 ARTHREX INC.
TABLE 158 ARTHREX INC.: BUSINESS OVERVIEW
11.1.2 SMITH & NEPHEW PLC
TABLE 159 SMITH & NEPHEW PLC: BUSINESS OVERVIEW
FIGURE 35 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2020)
11.1.3 JOHNSON & JOHNSON
TABLE 160 JOHNSON & JOHNSON: BUSINESS OVERVIEW
FIGURE 36 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2020)
11.1.4 BECTON, DICKINSON & COMPANY
TABLE 161 BECTON, DICKINSON & COMPANY: BUSINESS OVERVIEW
FIGURE 37 BECTON, DICKINSON & COMPANY: COMPANY SNAPSHOT (2020)
11.1.5 STRYKER CORPORATION
TABLE 162 STRYKER CORPORATION: BUSINESS OVERVIEW
FIGURE 38 STRYKER CORPORATION: COMPANY SNAPSHOT (2020)
11.1.6 MEDTRONIC PLC.
TABLE 163 MEDTRONIC PLC.: BUSINESS OVERVIEW
FIGURE 39 MEDTRONIC PLC.: COMPANY SNAPSHOT (2020)
11.1.7 ZIMMER BIOMET
TABLE 164 ZIMMER BIOMET: BUSINESS OVERVIEW
FIGURE 40 ZIMMER BIOMET: COMPANY SNAPSHOT (2020)
11.1.8 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
TABLE 165 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: BUSINESS OVERVIEW
FIGURE 41 INTEGRA LIFESCIENCES HOLDINGS CORPORATION:
COMPANY SNAPSHOT (2020)
11.1.9 CRYOLIFE INC.
TABLE 166 CRYOLIFE INC.: BUSINESS OVERVIEW
FIGURE 42 CRYOLIFE INC.: COMPANY SNAPSHOT (2020)
11.1.10 ORGANOGENESIS INC.
TABLE 167 ORGANOGENESIS INC.: BUSINESS OVERVIEW
FIGURE 43 ORGANOGENESIS INC.: COMPANY SNAPSHOT (2020)
11.2 OTHER PLAYERS
11.2.1 LIFENET HEALTH INC.
TABLE 168 LIFENET HEALTH INC.: BUSINESS OVERVIEW
11.2.2 BAXTER INTERNATIONAL, INC.
TABLE 169 BAXTER INTERNATIONAL, INC.: BUSINESS OVERVIEW
FIGURE 44 BAXTER INTERNATIONAL: COMPANY SNAPSHOT (2020)
11.2.3 TISSUE REGENIX GROUP PLC
TABLE 170 TISSUE REGENIX GROUP PLC: BUSINESS OVERVIEW
FIGURE 45 TISSUE REGENIX GROUP PLC: COMPANY SNAPSHOT (2020)
11.2.4 CONMED CORPORATION
TABLE 171 CONMED CORPORATION: BUSINESS OVERVIEW
FIGURE 46 CONMED CORPORATION: COMPANY SNAPSHOT (2020)
11.2.5 MERIL LIFE SCIENCES PVT. LTD.
TABLE 172 MERIL LIFE SCIENCES PVT. LTD.: BUSINESS OVERVIEW
11.2.6 RTI SURGICAL
TABLE 173 RTI SURGICAL: BUSINESS OVERVIEW
11.2.7 SAMYANG HOLDINGS CORPORATION
TABLE 174 SAMYANG HOLDINGS CORPORATION: BUSINESS OVERVIEW
11.2.8 AROA BIOSURGERY LTD.
TABLE 175 AROA BIOSURGERY LTD.: BUSINESS OVERVIEW
11.2.9 ACERA SURGICAL INC.
TABLE 176 ACERA SURGICAL INC.: BUSINESS OVERVIEW
11.2.10 ORTHOCELL LTD.
TABLE 177 ORTHOCELL LTD.: BUSINESS OVERVIEW
11.2.11 ACELL INC.
TABLE 178 ACELL INC.: BUSINESS OVERVIEW
11.2.12 BIOCER ENTWICKLUNGS-GMBH
TABLE 179 BIOCER ENTWICKLUNGS-GMBH: BUSINESS OVERVIEW
11.2.13 ISTO BIOLOGICS
TABLE 180 ISTO BIOLOGICS: BUSINESS OVERVIEW
11.2.14 BETATECH MEDICAL
TABLE 181 BETATECH MEDICAL: BUSINESS OVERVIEW
11.2.15 MIMEDX
TABLE 182 MIMEDX: BUSINESS OVERVIEW
FIGURE 47 MIMEDX: COMPANY SNAPSHOT (2020)
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INDUSTRY INSIGHTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 MARKETS COVERED – BY REGION
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Breakdown of primaries
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2020)
FIGURE 5 SUPPLY-SIDE ANALYSIS: SOFT TISSUE REPAIR MARKET
FIGURE 6 TOP-DOWN APPROACH
FIGURE 7 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE SOFT TISSUE REPAIR MARKET (2022–2027)
2.3 GROWTH FORECAST
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF THE SOFT TISSUE
REPAIR MARKET (2021)
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.5 KEY INDUSTRY INSIGHTS
2.6 LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
2.8 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
FIGURE 10 SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 11 SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 12 SOFT TISSUE REPAIR MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE SOFT TISSUE REPAIR MARKET
4 PREMIUM INSIGHTS
4.1 SOFT TISSUE REPAIR SYSTEM MARKET OVERVIEW
FIGURE 14 INCREASING HERNIA CASES AND TRAUMA INJURIES AND
GROWING R&D DRIVE THE MARKET
4.2 REGIONAL MIX: SOFT TISSUE REPAIR MARKET
FIGURE 15 APAC TO REGISTER THE HIGHEST CAGR OF DURING THE FORECAST PERIOD
4.3 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET, BY PRODUCT AND COUNTRY (2021)
FIGURE 16 TISSUE PATCHES/MESHES ACCOUNTED FOR THE LARGEST SHARE
OF THE ASIA PACIFIC MARKET IN 2021
4.4 SOFT TISSUE REPAIR MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 CHINA TO REGISTER THE HIGHEST REVENUE GROWTH DURING
THE FORECAST PERIOD
4.5 SOFT TISSUE REPAIR MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 18 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE
DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Increasing aging population and obesity rate
5.2.1.2 Growing incidence of sports injuries
5.2.1.3 Strong focus on R&D
5.2.1.4 Increasing volume of surgeries and growing prevalence of
severe trauma injuries
TABLE 2 UK: INCREASE IN THE NUMBER OF CARDIAC SURGICAL
PROCEDURES PERFORMED
5.2.2 RESTRAINTS
5.2.2.1 Unfavorable reimbursement scenario
5.2.2.2 High product and procedure costs
5.2.3 OPPORTUNITIES
5.2.3.1 Growing adoption of advanced soft tissue repair products in emerging markets
TABLE 3 COST OF SURGICAL PROCEDURES: US VS. INDIA (USD)
5.2.3.2 Growing use of combination materials for enhancing product efficacy
5.2.4 CHALLENGES
5.2.4.1 Stringent regulatory framework
5.2.4.2 Need for skilled personnel
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON ECONOMIC SCENARIO IN
SOFT TISSUE REPAIR MARKET
5.4 ECOSYSTEM ANALYSIS
FIGURE 19 SOFT TISSUE REPAIR MARKET: ECOSYSTEM ANALYSIS
5.5 PRICING ANALYSIS
TABLE 4 AVERAGE SELLING PRICE FOR SOFT TISSUE REPAIR PRODUCTS
5.6 SUPPLY CHAIN ANALYSIS
FIGURE 20 SUPPLY CHAIN ANALYSIS: SOFT TISSUE REPAIR MARKET (2021)
5.7 PATENT ANALYSIS
5.7.1 PATENT PUBLICATION TRENDS FOR SOFT TISSUE REPAIR MARKET
FIGURE 21 GLOBAL PATENT PUBLICATION TRENDS IN SOFT TISSUE REPAIR, 2016–2021
5.7.2 TOP APPLICANTS (COMPANIES) OF SOFT TISSUE REPAIR PATENTS
FIGURE 22 TOP COMPANIES THAT APPLIED FOR SOFT TISSUE REPAIR PRODUCT PATENTS, 2016–2021
5.7.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE SOFT TISSUE REPAIR MARKET
FIGURE 23 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR SOFT TISSUE REPAIR PATENTS, 2016–2021
5.8 VALUE CHAIN ANALYSIS
FIGURE 24 SOFT TISSUE REPAIR MARKET: VALUE CHAIN ANALYSIS (2021)
5.9 TECHNOLOGY ANALYSIS
5.10 KEY CONFERENCES & EVENTS IN 2022–2023
5.11 REGULATORY LANDSCAPE
TABLE 5 REGULATORY STANDARDS/APPROVALS REQUIRED FOR SOFT TISSUE
REPAIR PRODUCTS, BY COUNTRY/REGION
5.12 PORTER’S FIVE FORCES ANALYSIS
TABLE 6 SOFT TISSUE REPAIR MARKET: PORTER’S FIVE FORCES ANALYSIS
5.12.1 THREAT FROM NEW ENTRANTS
5.12.2 COMPETITIVE RIVALRY
5.12.3 BARGAINING POWER OF BUYERS
5.12.4 BARGAINING POWER OF SUPPLIERS
5.12.5 THREAT FROM SUBSTITUTES
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 25 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS
FOR TOP 3 APPLICATIONS
TABLE 7 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS
FOR TOP 3 APPLICATIONS (%)
5.13.2 BUYING CRITERIA
FIGURE 26 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
TABLE 8 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
6 SOFT TISSUE REPAIR MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 9 SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
6.2 TISSUE PATCHES/MESHES
TABLE 10 SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 11 SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
6.2.1 SYNTHETIC MESHES
6.2.1.1 Growing popularity is attributed to the availability of raw materials, lack of infectious disease transmission, cost-effectiveness
TABLE 12 SOFT TISSUE REPAIR MARKET FOR SYNTHETIC MESHES, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2 BIOLOGICAL MESHES
TABLE 13 SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 14 SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
6.2.2.1 Allografts
6.2.2.1.1 Biocompatibility and superior aesthetic results drive the use of allografts
TABLE 15 SOFT TISSUE REPAIR MARKET FOR ALLOGRAFTS, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2.2 Xenografts
6.2.2.2.1 Xenografts are more viable than allografts due to availability and size ranges
TABLE 16 SOFT TISSUE REPAIR MARKET FOR XENOGRAFTS, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.3 FIXATION PRODUCTS
TABLE 17 SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 18 SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
6.2.3.1 Suture anchors
6.2.3.1.1 Growing injury incidence and need for surgery drive demand for suture anchors
TABLE 19 SOFT TISSUE REPAIR MARKET FOR SUTURE ANCHORS, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.3.2 Interference screws
6.2.3.2.1 Availability of advanced biodegradable screws and development of biocomposites drives the market growth
TABLE 20 SOFT TISSUE REPAIR MARKET FOR INTERFERENCE SCREWS, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.3.3 Other fixation products
TABLE 21 SOFT TISSUE REPAIR MARKET FOR OTHER FIXATION PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 LAPAROSCOPIC INSTRUMENTS
6.3.1 QUICK RECOVERY, LOW PAIN & INFECTION RATES DRIVE DEMAND FOR LAPAROSCOPIC SURGERY AND ASSOCIATED INSTRUMENTS
TABLE 22 SOFT TISSUE REPAIR MARKET FOR LAPAROSCOPIC INSTRUMENTS, BY COUNTRY, 2020–2027 (USD MILLION)
7 SOFT TISSUE REPAIR MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 23 SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
7.2 HERNIA REPAIR
7.2.1 HERNIA REPAIR ACCOUNTS FOR THE LARGEST SHARE OF
THE SOFT TISSUE REPAIR MARKET
TABLE 24 SOFT TISSUE REPAIR MARKET FOR HERNIA REPAIR, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 SKIN REPAIR
7.3.1 INCREASING CASES OF CHRONIC WOUNDS, DIABETIC ULCERS, AND BURNS CONTRIBUTE TO GROWTH OF SKIN REPAIR MARKET
TABLE 25 SOFT TISSUE REPAIR MARKET FOR SKIN REPAIR, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 ORTHOPEDIC REPAIR
7.4.1 INCREASING NUMBER OF SPORTS INJURIES DRIVES
ORTHOPEDIC REPAIR MARKET
TABLE 26 SOFT TISSUE REPAIR MARKET FOR ORTHOPEDIC REPAIR, BY COUNTRY, 2020–2027 (USD MILLION)
7.5 DENTAL REPAIR
7.5.1 RISING DEMAND FOR PREVENTIVE AND COSMETIC DENTAL PROCEDURES DRIVES THE DENTAL REPAIR MARKET
TABLE 27 SOFT TISSUE REPAIR MARKET FOR DENTAL REPAIR, BY COUNTRY, 2020–2027 (USD MILLION)
7.6 BREAST RECONSTRUCTION
7.6.1 RISING BREAST CANCER PREVALENCE SUPPORTS MARKET GROWTH
TABLE 28 SOFT TISSUE REPAIR MARKET FOR BREAST RECONSTRUCTION, BY COUNTRY, 2020–2027 (USD MILLION)
7.7 DURAL REPAIR
7.7.1 RISING PREVALENCE OF NEUROVASCULAR DISORDERS AND AWARENESS DRIVES THE DURAL SOFT TISSUE REPAIR MARKET
TABLE 29 SOFT TISSUE REPAIR MARKET FOR DURAL REPAIR, BY COUNTRY, 2020–2027 (USD MILLION)
7.8 VAGINAL SLING PROCEDURES
7.8.1 DEMAND FOR VAGINAL SLING PROCEDURES BOLSTERED BY GROWING CASES OF STRESS-INDUCED URINARY INCONTINENCE (SUI) IN WOMEN
TABLE 30 SOFT TISSUE REPAIR MARKET FOR VAGINAL SLING PROCEDURES, BY COUNTRY, 2020–2027 (USD MILLION)
7.9 OTHER APPLICATIONS
TABLE 31 SOFT TISSUE REPAIR MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
8 SOFT TISSUE REPAIR MARKET, BY END USER
8.1 INTRODUCTION
TABLE 32 SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2 HOSPITALS
8.2.1 HOSPITALS ARE THE LARGEST END USERS OF
SOFT TISSUE REPAIR PRODUCTS
TABLE 33 SOFT TISSUE REPAIR MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 CLINICS
8.3.1 QUICKER CONSULTATION SERVICES AND MINIMAL PATIENT STAYS ARE ADVANTAGES OFFERED BY CLINICS OVER HOSPITALS
TABLE 34 SOFT TISSUE REPAIR MARKET FOR CLINICS, BY COUNTRY, 2020–2027(USD MILLION)
8.4 OTHER END USERS
TABLE 35 SOFT TISSUE REPAIR MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
9 SOFT TISSUE REPAIR MARKET, BY REGION
9.1 INTRODUCTION
FIGURE 27 INDIA AND CHINA TO REGISTER HIGHEST GROWTH RATES IN THE
SOFT TISSUE REPAIR MARKET
TABLE 36 SOFT TISSUE REPAIR MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 28 NORTH AMERICA: SOFT TISSUE REPAIR MARKET SNAPSHOT
TABLE 37 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 38 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 39 NORTH AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 40 NORTH AMERICA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 41 NORTH AMERICA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 42 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 43 NORTH AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.1 US
9.2.1.1 Presence of prominent market players and high per capita income supports market growth in the US
TABLE 44 US: MACROECONOMIC INDICATORS
TABLE 45 US: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 46 US: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 47 US: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 48 US: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 49 US: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 50 US: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Rising healthcare expenditure and favorable public and private funding supports soft tissue repair market growth
TABLE 51 CANADA: MACROECONOMIC INDICATORS
TABLE 52 CANADA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 53 CANADA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 54 CANADA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 55 CANADA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 56 CANADA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 57 CANADA: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3 EUROPE
FIGURE 29 EUROPE: SOFT TISSUE REPAIR MARKET SNAPSHOT
TABLE 58 EUROPE: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 59 EUROPE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 60 EUROPE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 61 EUROPE: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 62 EUROPE: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 63 EUROPE: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 64 EUROPE: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Germany holds the largest share of the European market
TABLE 65 GERMANY: MACROECONOMIC INDICATORS
TABLE 66 GERMANY: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 67 GERMANY: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 68 GERMANY: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 69 GERMANY: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 70 GERMANY: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 71 GERMANY: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.2 FRANCE
9.3.2.1 Presence of a well-established healthcare system and growing geriatric population to boost the market growth
TABLE 72 FRANCE: MACROECONOMIC INDICATORS
TABLE 73 FRANCE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 74 FRANCE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 75 FRANCE: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 76 FRANCE: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 77 FRANCE: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 78 FRANCE: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.3 UK
9.3.3.1 Growing volume of hernia repair surgeries and cardiovascular surgeries in the UK stimulating market growth
TABLE 79 UK: MACROECONOMIC INDICATORS
TABLE 80 UK: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 81 UK: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 82 UK: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 83 UK: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 84 UK: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 85 UK: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Increasing volume of surgeries to drive the demand for soft tissue repair products in the country
TABLE 86 ITALY: MACROECONOMIC INDICATORS
TABLE 87 ITALY: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 88 ITALY: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 89 ITALY: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 90 ITALY: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 91 ITALY: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 92 ITALY: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Growing healthcare budget and rising efforts for boosting the local manufacturing of medical products to drive market growth
TABLE 93 SPAIN: MACROECONOMIC INDICATORS
TABLE 94 SPAIN: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 95 SPAIN: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 96 SPAIN: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 97 SPAIN: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 98 SPAIN: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 99 SPAIN: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 100 ROE: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 101 ROE: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 102 ROE: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 ROE: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 104 ROE: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 105 ROE: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 30 ASIA PACIFIC: SOFT TISSUE REPAIR MARKET SNAPSHOT
TABLE 106 APAC: SOFT TISSUE REPAIR MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 107 APAC: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 108 APAC: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 109 APAC: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 110 APAC: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 111 APAC: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 112 APAC: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Strong healthcare system and rising geriatric population to support market growth in Japan
TABLE 113 JAPAN: MACROECONOMIC INDICATORS
TABLE 114 JAPAN: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 115 JAPAN: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 116 JAPAN: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 117 JAPAN: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 118 JAPAN: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 119 JAPAN: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Growing number of hospitals and healthcare policy reforms stimulating market growth
TABLE 120 CHINA: MACROECONOMIC INDICATORS
TABLE 121 CHINA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 122 CHINA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 123 CHINA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 124 CHINA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 125 CHINA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 126 CHINA: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Rising healthcare awareness and favorable government support to stimulate market growth in India
TABLE 127 INDIA: MACROECONOMIC INDICATORS
TABLE 128 INDIA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 129 INDIA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 130 INDIA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 131 INDIA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 132 INDIA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 133 INDIA: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 134 ROAPAC: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 135 ROAPAC: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 136 ROAPAC: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 137 ROAPAC: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 138 ROAPAC: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 139 ROAPAC: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 LOW-COST SURGERIES ATTRACT MEDICAL TOURISTS TO LATIN AMERICA
TABLE 140 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 141 LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 142 LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 143 LATIN AMERICA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 144 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 145 LATIN AMERICA: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 MEA IS THE SMALLEST REGIONAL MARKET FOR BIOSURGERY PRODUCTS
TABLE 146 MEA: SOFT TISSUE REPAIR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 147 MEA: SOFT TISSUE REPAIR MARKET FOR TISSUE PATCHES/MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 148 MEA: SOFT TISSUE REPAIR MARKET FOR BIOLOGICAL MESHES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 149 MEA: SOFT TISSUE REPAIR MARKET FOR FIXATION PRODUCTS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 150 MEA: SOFT TISSUE REPAIR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 151 MEA: SOFT TISSUE REPAIR MARKET, BY END USER, 2020–2027 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 31 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE
SOFT TISSUE REPAIR MARKET
10.4 MARKET SHARE ANALYSIS
FIGURE 32 SOFT TISSUE REPAIR MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
10.5 COMPANY EVALUATION QUADRANT
10.5.1 STARS
10.5.2 PERVASIVE PLAYERS
10.5.3 EMERGING LEADERS
10.5.4 PARTICIPANTS
FIGURE 33 SOFT TISSUE REPAIR MARKET: COMPANY EVALUATION MATRIX, 2021
10.6 COMPETITIVE LEADERSHIP MAPPING FOR SMES & START-UPS
10.6.1 PROGRESSIVE COMPANIES
10.6.2 DYNAMIC COMPANIES
10.6.3 STARTING BLOCKS
10.6.4 RESPONSIVE COMPANIES
FIGURE 34 SOFT TISSUE REPAIR MARKET: COMPANY EVALUATION MATRIX
FOR SMES & START-UP
10.7 COMPETITIVE BENCHMARKING
10.7.1 OVERALL COMPANY FOOTPRINT
TABLE 152 OVERALL COMPANY FOOTPRINT (25 COMPANIES)
TABLE 153 COMPANY FOOTPRINT: BY PRODUCT (25 COMPANIES)
TABLE 154 COMPANY FOOTPRINT: BY APPLICATION (25 COMPANIES)
TABLE 155 COMPANY FOOTPRINT: BY REGION (25 COMPANIES)
10.8 COMPETITIVE SCENARIO
10.8.1 DEALS
TABLE 156 DEALS
10.8.2 OTHER DEVELOPMENTS
TABLE 157 OTHER DEVELOPMENTS
11 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, and MnM View)*
11.1 KEY PLAYERS
11.1.1 ARTHREX INC.
TABLE 158 ARTHREX INC.: BUSINESS OVERVIEW
11.1.2 SMITH & NEPHEW PLC
TABLE 159 SMITH & NEPHEW PLC: BUSINESS OVERVIEW
FIGURE 35 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2020)
11.1.3 JOHNSON & JOHNSON
TABLE 160 JOHNSON & JOHNSON: BUSINESS OVERVIEW
FIGURE 36 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2020)
11.1.4 BECTON, DICKINSON & COMPANY
TABLE 161 BECTON, DICKINSON & COMPANY: BUSINESS OVERVIEW
FIGURE 37 BECTON, DICKINSON & COMPANY: COMPANY SNAPSHOT (2020)
11.1.5 STRYKER CORPORATION
TABLE 162 STRYKER CORPORATION: BUSINESS OVERVIEW
FIGURE 38 STRYKER CORPORATION: COMPANY SNAPSHOT (2020)
11.1.6 MEDTRONIC PLC.
TABLE 163 MEDTRONIC PLC.: BUSINESS OVERVIEW
FIGURE 39 MEDTRONIC PLC.: COMPANY SNAPSHOT (2020)
11.1.7 ZIMMER BIOMET
TABLE 164 ZIMMER BIOMET: BUSINESS OVERVIEW
FIGURE 40 ZIMMER BIOMET: COMPANY SNAPSHOT (2020)
11.1.8 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
TABLE 165 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: BUSINESS OVERVIEW
FIGURE 41 INTEGRA LIFESCIENCES HOLDINGS CORPORATION:
COMPANY SNAPSHOT (2020)
11.1.9 CRYOLIFE INC.
TABLE 166 CRYOLIFE INC.: BUSINESS OVERVIEW
FIGURE 42 CRYOLIFE INC.: COMPANY SNAPSHOT (2020)
11.1.10 ORGANOGENESIS INC.
TABLE 167 ORGANOGENESIS INC.: BUSINESS OVERVIEW
FIGURE 43 ORGANOGENESIS INC.: COMPANY SNAPSHOT (2020)
11.2 OTHER PLAYERS
11.2.1 LIFENET HEALTH INC.
TABLE 168 LIFENET HEALTH INC.: BUSINESS OVERVIEW
11.2.2 BAXTER INTERNATIONAL, INC.
TABLE 169 BAXTER INTERNATIONAL, INC.: BUSINESS OVERVIEW
FIGURE 44 BAXTER INTERNATIONAL: COMPANY SNAPSHOT (2020)
11.2.3 TISSUE REGENIX GROUP PLC
TABLE 170 TISSUE REGENIX GROUP PLC: BUSINESS OVERVIEW
FIGURE 45 TISSUE REGENIX GROUP PLC: COMPANY SNAPSHOT (2020)
11.2.4 CONMED CORPORATION
TABLE 171 CONMED CORPORATION: BUSINESS OVERVIEW
FIGURE 46 CONMED CORPORATION: COMPANY SNAPSHOT (2020)
11.2.5 MERIL LIFE SCIENCES PVT. LTD.
TABLE 172 MERIL LIFE SCIENCES PVT. LTD.: BUSINESS OVERVIEW
11.2.6 RTI SURGICAL
TABLE 173 RTI SURGICAL: BUSINESS OVERVIEW
11.2.7 SAMYANG HOLDINGS CORPORATION
TABLE 174 SAMYANG HOLDINGS CORPORATION: BUSINESS OVERVIEW
11.2.8 AROA BIOSURGERY LTD.
TABLE 175 AROA BIOSURGERY LTD.: BUSINESS OVERVIEW
11.2.9 ACERA SURGICAL INC.
TABLE 176 ACERA SURGICAL INC.: BUSINESS OVERVIEW
11.2.10 ORTHOCELL LTD.
TABLE 177 ORTHOCELL LTD.: BUSINESS OVERVIEW
11.2.11 ACELL INC.
TABLE 178 ACELL INC.: BUSINESS OVERVIEW
11.2.12 BIOCER ENTWICKLUNGS-GMBH
TABLE 179 BIOCER ENTWICKLUNGS-GMBH: BUSINESS OVERVIEW
11.2.13 ISTO BIOLOGICS
TABLE 180 ISTO BIOLOGICS: BUSINESS OVERVIEW
11.2.14 BETATECH MEDICAL
TABLE 181 BETATECH MEDICAL: BUSINESS OVERVIEW
11.2.15 MIMEDX
TABLE 182 MIMEDX: BUSINESS OVERVIEW
FIGURE 47 MIMEDX: COMPANY SNAPSHOT (2020)
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INDUSTRY INSIGHTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
The soft tissue repair market is expected to reach $14.7 billion in 2019 from $10.3 billion in 2014, at a healthy CAGR of 7.5% from 2014 to 2019.
Growth in this market is attributed to the increasing incidence of soft tissue injuries, increasing healthcare expenditure, lack of substitutes for soft tissue repair surgery, increasing aging population & obesity rate, and geographic expansion by leading players in emerging markets.
The global soft tissue repair market is segmented by product, application, and region. This report also discusses key market drivers, restraints, opportunities, and challenges for this market and submarkets. The market, by products, is segmented into tissue patches/meshes, soft tissue fixation devices, and laparoscopic instruments.
Key players in Soft Tissue Repair Market are LifeCell Corporation (U.S.), Organogenesis (U.S.), C.R. Bard, Inc. (U.S.), Johnson & Johnson (U.S.), Covidien plc (Ireland), Arthrex Inc. (U.S.), Smith & Nephew plc (U.K.), Integra Lifesciences Corporation (U.S.), Wright Medical Technology (U.S.), and Stryker Corporation (U.S.).
North America, a major market for global soft tissue repair, occupied a major share in this market, closely followed by Europe. However, emerging countries in the Asia-Pacific region and the Rest of the World (Latin America) are expected to record strong growth during the forecast period. Countries like India, China, and Brazil will majorly drive market growth owing to rising investments by public and private players to provide improved healthcare services in these countries, the presence of a large patient population, and the focus of leading players on capturing growth opportunities in these markets.
